Literature DB >> 15890151

Predictors of positive axillary lymph nodes in breast cancer patients with metastatic sentinel lymph node.

Isabel Peixoto Callejo1, José Américo Brito, José Wheinholtz Bivar, Fernando Jesus Fernandes, João Leal Faria, María Saudade André, Carlos Santos Costa, M Odette Almeida, J Meneses e Sousa.   

Abstract

INTRODUCTION: Breast cancer with metastatic sentinel lymph nodes (SLN) may have clinico-pathologic factors associated with the presence of positive non-sentinel axillary nodes (NSLN). The aim of the present study was to determine factors that predict involvement of NSLN in breast cancer patients with positive SLN.
MATERIAL AND METHODS: A prospective database search identified 80 patients who underwent SLN biopsy for invasive breast cancer between January 1999 and August 2002. Clinico-pathologic data was analyzed to determine factors that predicted additional positive axillary nodes.
RESULTS: A total of 23 patients had positive SLN and underwent conventional axillary lymph node dissection. Statistical analysis revealed that lympho-vascular invasion (p~0.00000), SLN metastasis >2 mm (p=0.002), and the presence of extra-nodal involvement (p=0.002), were positive predictors of the metastatic involvement of NSLN.
CONCLUSIONS: The likelihood of positive NSLN correlates with pathologic parameters such as the presence of lympho-vascular invasion, size of the SLN metastasis, and extra-nodal involvement. These data may be helpful with the regard to the decision to undertake axillary dissection in breast cancer patients with metastatic sentinel lymph nodes.

Entities:  

Mesh:

Year:  2005        PMID: 15890151     DOI: 10.1007/bf02710021

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  29 in total

1.  Minimal solid tumor involvement of regional and distant sites: when is a metastasis not a metastasis?

Authors:  D L Page; T J Anderson; B A Carter
Journal:  Cancer       Date:  1999-12-15       Impact factor: 6.860

2.  Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status.

Authors:  I J Diel; M Kaufmann; S D Costa; R Holle; G von Minckwitz; E F Solomayer; S Kaul; G Bastert
Journal:  J Natl Cancer Inst       Date:  1996-11-20       Impact factor: 13.506

3.  Sentinel lymphadenectomy in breast cancer.

Authors:  A E Giuliano; R C Jones; M Brennan; R Statman
Journal:  J Clin Oncol       Date:  1997-06       Impact factor: 44.544

4.  Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection?

Authors:  K U Chu; R R Turner; N M Hansen; M B Brennan; A Bilchik; A E Giuliano
Journal:  Ann Surg       Date:  1999-04       Impact factor: 12.969

5.  Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes.

Authors:  U Veronesi; G Paganelli; V Galimberti; G Viale; S Zurrida; M Bedoni; A Costa; C de Cicco; J G Geraghty; A Luini; V Sacchini; P Veronesi
Journal:  Lancet       Date:  1997-06-28       Impact factor: 79.321

6.  Predictors of positive axillary lymph nodes after sentinel lymph node biopsy in breast cancer.

Authors:  S F Abdessalam; E E Zervos; M Prasad; W B Farrar; L D Yee; M J Walker; W B Carson; W E Burak
Journal:  Am J Surg       Date:  2001-10       Impact factor: 2.565

7.  Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer?

Authors:  C Reynolds; R Mick; J H Donohue; C S Grant; D R Farley; L S Callans; S G Orel; G L Keeney; T J Lawton; B J Czerniecki
Journal:  J Clin Oncol       Date:  1999-06       Impact factor: 44.544

8.  Recommendations for sentinel lymph node processing in breast cancer.

Authors:  M A Yared; L P Middleton; T L Smith; H W Kim; M I Ross; K K Hunt; A A Sahin
Journal:  Am J Surg Pathol       Date:  2002-03       Impact factor: 6.394

9.  Sentinel node biopsy in breast cancer.

Authors:  J M Barnwell; M A Arredondo; D Kollmorgen; J F Gibbs; D Lamonica; W Carson; P Zhang; J Winston; S B Edge
Journal:  Ann Surg Oncol       Date:  1998-03       Impact factor: 5.344

10.  Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials.

Authors: 
Journal:  N Engl J Med       Date:  1995-11-30       Impact factor: 91.245

View more
  5 in total

1.  In stage II/III lymph node-positive breast cancer patients less than 55 years of age, keratin 8 expression in lymph node metastases but not in the primary tumour is an indicator of better survival.

Authors:  Serena Bonin; Danae Pracella; Renzo Barbazza; Sandro Sulfaro; Giorgio Stanta
Journal:  Virchows Arch       Date:  2015-02-28       Impact factor: 4.064

Review 2.  Axillary surgery in breast cancer patients.

Authors:  A Millet; C A Fuster; A Lluch; F Dirbas
Journal:  Clin Transl Oncol       Date:  2007-08       Impact factor: 3.405

3.  Analysis of sentinel lymph node biopsy and non-sentinel lymph node metastasis in invasive ductal and invasive lobular breast cancer: a nationwide cross-sectional study (CSBrS-001).

Authors:  Juliang Zhang; Yuwei Ling; Ting Wang; Changjiao Yan; Meiling Huang; Zhimin Fan; Rui Ling
Journal:  Ann Transl Med       Date:  2021-10

4.  A novel nomogram for decision-making assistance on exemption of axillary lymph node dissection in T1-2 breast cancer with only one sentinel lymph node metastasis.

Authors:  Lei Liu; Yaoxin Lin; Guozheng Li; Lei Zhang; Xin Zhang; Jiale Wu; Xinheng Wang; Yumei Yang; Shouping Xu
Journal:  Front Oncol       Date:  2022-09-12       Impact factor: 5.738

5.  Lymph node shape in computed tomography imaging as a predictor for axillary lymph node metastasis in patients with breast cancer.

Authors:  Goro Kutomi; Tousei Ohmura; Fukino Satomi; Tomoko Takamaru; Hiroaki Shima; Yasuyo Suzuki; Seiko Otokozawa; Hitoshi Zembutsu; Mitsuru Mori; Koichi Hirata
Journal:  Exp Ther Med       Date:  2014-06-16       Impact factor: 2.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.